Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
Clinical trial NCT06557889 · RECRUITING
Trial details
- NCT number
- NCT06557889
- Sponsor
- Institut Claudius Regaud
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2030-09-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.